Zinc has been used in patients with acne vulgaris for its anti-inflammatory effects; however, it is unclear if zinc supplementation is also beneficial in other inflammatory skin conditions.
The objective of this article was to determine the effect of zinc supplementation on inflammatory dermatologic conditions.
We searched the Cochrane Central Register of Controlled Trials, EMBASE, MEDLINE, and Ovid with no time limit up to 29 May, 2019. Trials examining supplementation with zinc in the treatment of inflammatory dermatological conditions (acne vulgaris, atopic dermatitis, diaper dermatitis, hidradenitis suppurativa, psoriasis, and rosacea) in children and adults were selected.
Of 229 articles, 22 met inclusion criteria. Supplementation with zinc was found to be beneficial in ten of 14 studies evaluating its effects on acne vulgaris, one of two studies on atopic dermatitis, one of one study on diaper dermatitis, and three of three studies evaluating its effects on hidradenitis suppurativa. However, the one article found on psoriasis and the one article found on rosacea showed no significant benefit of zinc treatment on disease outcome.
Conclusions and implications
Some preliminary evidence supports the use of zinc in the treatment of acne vulgaris and hidradenitis suppurativa; however, more research is needed with similar methodologies and larger sample sizes in these diseases. Further, zinc may be of some benefit in the treatment plan for atopic dermatitis and diaper dermatitis; however, additional studies should be conducted to further evaluate these potentially positive associations. To date, no evidence is available to suggest that zinc may be of benefit in rosacea and psoriasis; however, limited data are available evaluating the use of zinc in these conditions.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Roohani N, Hurrell R, Kelishadi R, Schulin R. Zinc and its importance for human health: an integrative review. J Res Med Sci. 2013;18(2):144–57.
Jurowski K, Szewczyk B, Nowak G, Piekoszewski W. Biological consequences of zinc deficiency in the pathomechanisms of selected diseases. J Biol Inorg Chem. 2014;19(7):1069–79. https://doi.org/10.1007/s00775-014-1139-0.
World Health Organization. Chapter 4: Childhood and maternal undernutrition. Geneva: World Health Organization; 2019.
Institute of Medicine FaNB. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, DC: National Academy Press; 2001.
Ervin RB, Kennedy-Stephenson J. Mineral intakes of elderly adult supplement and non-supplement users in the third national health and nutrition examination survey. J Nutr. 2002;132(11):3422–7. https://doi.org/10.1093/jn/132.11.3422.
Dixon LB, Winkleby MA, Radimer KL. Dietary intakes and serum nutrients differ between adults from food-insufficient and food-sufficient families: Third National Health and Nutrition Examination Survey, 1988-1994. J Nutr. 2001;131(4):1232–46. https://doi.org/10.1093/jn/131.4.1232.
Gholizadeh N, Mehdipour M, Najafi S, Bahramian A, Garjani S, Khoeini Poorfar H. Evaluation of the serum zinc level in erosive and non-erosive oral lichen planus. J Dent (Shiraz). 2014;15(2):52–6.
David TJ, Wells FE, Sharpe TC, Gibbs AC. Low serum zinc in children with atopic eczema. Br J Dermatol. 1984;111(5):597–601. https://doi.org/10.1111/j.1365-2133.1984.tb06630.x.
Saglam K, Serce AF, Yilmaz MI, Bulucu F, Aydin A, Akay C, et al. Trace elements and antioxidant enzymes in Behçet’s disease. Rheumatol Int. 2002;22(3):93–6. https://doi.org/10.1007/s00296-002-0195-x.
Bhatia ND, Vlahovic TC, Green LG, Martin G, Lin T. Halobetasol 0.01% lotion in the treatment of moderate-to-severe plaque psoriasis of the lower extremities. J Drugs Dermatol. 2019;18(10):1029–36.
Latter G, Grice JE, Mohammed Y, Roberts MS, Benson HAE. Targeted topical delivery of retinoids in the management of acne vulgaris: current formulations and novel delivery systems. Pharmaceutics. 2019;11:10. https://doi.org/10.3390/pharmaceutics11100490.
Xu W, Meng K, Wu H, Miura T, Suzuki S, Chiyotanda M, et al. Vitamin K2 immunosuppressive effect on pediatric patients with atopic dermatitis. Pediatr Int. 2019. https://doi.org/10.1111/ped.14014. [Epub ahead of print].
Dreno B, Trossaert M, Boiteau HL, Litoux P. Zinc salts effects on granulocyte zinc concentration and chemotaxis in acne patients. Acta Derm Venereol. 1992;72(4):250–2.
Kitabayashi C, Fukada T, Kanamoto M, Ohashi W, Hojyo S, Atsumi T, et al. Zinc suppresses Th17 development via inhibition of STAT3 activation. Int Immunol. 2010;22(5):375–86. https://doi.org/10.1093/intimm/dxq017.
Jarrousse V, Castex-Rizzi N, Khammari A, Charveron M, Dreno B. Zinc salts inhibit in vitro Toll-like receptor 2 surface expression by keratinocytes. Eur J Dermatol. 2007;17(6):492–6. https://doi.org/10.1684/ejd.2007.0263.
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1–12.
Göransson K, Lidén S, Odsell L. Oral zinc in acne vulgaris: a clinical and methodological study. Acta Derm Venereol. 1978;58(5):443–8. https://doi.org/10.2340/0001555558443448.
Hillström L, Pettersson L, Hellbe L, Kjellin A, Leczinsky C, Nordwall C. Comparison of oral treatment with zinc sulphate and placebo in acne vulgaris. Br J Dermatol. 1977;97(6):681–4. https://doi.org/10.1111/j.1365-2133.1977.tb14277.x.
Chan H, Chan G, Santos J, Dee K, Co JK. A randomized, double-blind, placebo-controlled trial to determine the efficacy and safety of lactoferrin with vitamin E and zinc as an oral therapy for mild to moderate acne vulgaris. Int J Dermatol. 2017;56(6):686–90. https://doi.org/10.1111/ijd.13607.
Cunliffe W, Burke B, Dodman B, Gould D. A double-blind trial of a zinc sulphate/citrate complex and tetracycline in the treatment of acne vulgaris. Br J Dermatol. 1979;101(3):321–5.
Dreno B, Moyse D, Alirezai M, Amblard P, Auffret N, Beylot C, et al. Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris. Dermatology. 2001;203(2):135–40.
Michaëlsson G, Juhlin L, Ljunghall K. A double-blind study of the effect of zinc and oxytetracycline in acne vulgaris. Br J Dermatol. 1977;97(5):561–6.
Meynadier J. Efficacy and safety study of two zinc gluconate regimens in the treatment of inflammatory acne. Eur J Dermatol. 2000;10(4):269–73.
Michaëlsson G, Juhlin L, Vahlquist A. Effects of oral zinc and vitamin A in acne. Arch Dermatol. 1977;113(1):31–6.
Vahlquist A, Michaëlsson G, Juhlin L. Acne treatment with oral zinc and vitamin A: effects on the serum levels of zinc and retinol binding protein (RBP). Acta Derm Venereol. 1978;58(5):437–42.
Michaëlsson G. Oral zinc in acne. Acta Derm Venereol Suppl (Stockh). 1980;Suppl. 89:87–93.
Rebello T, Atherton DJ, Holden C. The effect of oral zinc administration on sebum free fatty acids in acne vulgaris. Acta Derm Venereol. 1986;66(4):305–10.
Verma K, Saini A, Dhamija S. Oral zinc sulphate therapy in acne vulgaris: a double-blind trial. Acta Derm Venereol. 1980;60(4):337–40.
Weimar V, Puhl S, Smith W, tenBroeke J. Zinc sulfate in acne vulgaris. Arch Dermatol. 1978;114(12):1776–8.
Ewing C, Gibbs A, Ashcroft C, David T. Failure of oral zinc supplementation in atopic eczema. Eur J Clin Nutr. 1991;45(10):507–10.
Kim J, Yoo S, Jeong M, Ko J, Ro Y. Hair zinc levels and the efficacy of oral zinc supplementation in patients with atopic dermatitis. Acta Derm Venereol. 2014;94(5):558–62. https://doi.org/10.2340/00015555-1772.
Collipp PJ. Effect of oral zinc supplements on diaper rash in normal infants. J Med Assoc Ga. 1989;78(9):621–3.
Hessam S, Sand M, Meier NM, Gambichler T, Scholl L, Bechara FG. Combination of oral zinc gluconate and topical triclosan: an anti-inflammatory treatment modality for initial hidradenitis suppurativa. J Dermatol Sci. 2016;84(2):197–202. https://doi.org/10.1016/j.jdermsci.2016.08.010.
Brocard A, Knol AC, Khammari A, Dreno B. Hidradenitis suppurativa and zinc: a new therapeutic approach: a pilot study. Dermatology. 2007;214(4):325–7. https://doi.org/10.1159/000100883.
Dreno B, Khammari A, Brocard A, Moyse D, Blouin E, Guillet G, et al. Hidradenitis suppurativa: the role of deficient cutaneous innate immunity. Arch Dermatol. 2012;148(2):182–6. https://doi.org/10.1001/archdermatol.2011.315.
Office of the Commissioner. FDA in brief: FDA issues final rule on safety and effectiveness for certain active ingredients in over-the-counter health care antiseptic hand washes and rubs in the medical setting. 2019. https://www.fda.gov/NewsEvents/Newsroom/FDAInBrief/ucm589474.htm.
Voorhees J, Chakrabarti S, Botero F, Miedler L, Harrell E. Zinc therapy and distribution in psoriasis. Arch Dermatol. 1969;100(6):669–73.
Bamford JT, Gessert CT, Haller IV, Kruger K, Johnson BP. Randomized, double-blind trial of 220 mg zinc sulfate twice daily in the treatment of rosacea. Int J Dermatol. 2012;51(4):459–62. https://doi.org/10.1111/j.1365-4632.2011.05353.x.
Weismann K, Wadskov S, Sondergaard J. Oral zinc sulphate therapy for acne vulgaris. Acta Derm Venereol. 1977;57(4):357–60.
Wegmüller R, Tay F, Zeder C, Brnic M, Hurrell RF. Zinc absorption by young adults from supplemental zinc citrate is comparable with that from zinc gluconate and higher than from zinc oxide. J Nutr. 2014;144(2):132–6. https://doi.org/10.3945/jn.113.181487.
Henderson LM, Brewer GJ, Dressman JB, Swidan SZ, DuRoss DJ, Adair CH, et al. Effect of intragastric pH on the absorption of oral zinc acetate and zinc oxide in young healthy volunteers. JPEN J Parenter Enteral Nutr. 1995;19(5):393–7. https://doi.org/10.1177/0148607195019005393.
Wolfe SA, Gibson RS, Gadowsky SL, O’Connor DL. Zinc status of a group of pregnant adolescents at 36 weeks gestation living in southern Ontario. J Am Coll Nutr. 1994;13(2):154–64. https://doi.org/10.1080/07315724.1994.10718389.
Siepmann M, Spank S, Kluge A, Schappach A, Kirch W. The pharmacokinetics of zinc from zinc gluconate: a comparison with zinc oxide in healthy men. Int J Clin Pharmacol Ther. 2005;43(12):562–5. https://doi.org/10.5414/cpp43562.
Barrie SA, Wright JV, Pizzorno JE, Kutter E, Barron PC. Comparative absorption of zinc picolinate, zinc citrate and zinc gluconate in humans. Agents Actions. 1987;21(1–2):223–8.
Guo CH, Wang CL. Effects of zinc supplementation on plasma copper/zinc ratios, oxidative stress, and immunological status in hemodialysis patients. Int J Med Sci. 2013;10(1):79–89. https://doi.org/10.7150/ijms.5291.
Cousins RJ. Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin. Physiol Rev. 1985;65(2):238–309. https://doi.org/10.1152/physrev.19220.127.116.11.
No sources of funding were received for the preparation of this article.
Conflict of interest
Raja K. Sivamani serves as a scientific advisor and editor to LearnHealth and as a consultant to Burt’s Bees and Dermala. Cindy J. Chambers serves as a consultant to Burt’s Bees. Simran Dhaliwal, Mimi Nguyen, Alexandra R. Vaughn, and Manisha Notay have no conflicts of interest that are directly relevant to the content of this article.
About this article
Cite this article
Dhaliwal, S., Nguyen, M., Vaughn, A.R. et al. Effects of Zinc Supplementation on Inflammatory Skin Diseases: A Systematic Review of the Clinical Evidence. Am J Clin Dermatol 21, 21–39 (2020). https://doi.org/10.1007/s40257-019-00484-0